Keyphrases
Peritoneal Dialysis
100%
Continuous Glucose Monitoring
50%
Hemoglobin A1c (HbA1c)
50%
Fructosamine
50%
Type 2 Diabetic Patients
50%
Standardized Meal
50%
Phosphorus
50%
Plasma Phosphate
50%
Acute Changes
50%
Randomized Trial
50%
High Phosphorus Content
16%
Low Phosphorus
16%
Plasma Glucose
14%
End-stage Kidney Disease
11%
Linear Regression
7%
Estimated Glomerular Filtration Rate
7%
Glycemic Monitoring
7%
Erythropoiesis-stimulating Agents
7%
Type 2 Diabetes Mellitus (T2DM)
7%
Monitoring Period
7%
Erythrocyte Lifespan
7%
Glucose Level
7%
Mean Group
7%
Clinical Significance
7%
A1c Levels
7%
Glycemic Status
7%
Interstitial Glucose
7%
Medtronic
7%
Maintenance Peritoneal Dialysis
5%
Blood Samples
5%
Negligible Effects
5%
High Phosphorus
5%
Chronic Kidney Disease
5%
Randomized Crossover
5%
Hyperphosphatemia
5%
Medicine and Dentistry
Peritoneal Dialysis
100%
Patient with Type 2 Diabetes
50%
Meal
50%
Fructosamine
50%
Hemoglobin A1c
50%
Glycemic
14%
End Stage Renal Disease
9%
Clinical Significance
7%
Maturity Onset Diabetes of the Young
7%
Erythropoietin
7%
Glomerular Filtration Rate
7%
Linear Regression Analysis
7%
Nonoxinol 9
7%
Analeptic
7%
Erythrocyte Lifespan
7%
Nursing and Health Professions
Peritoneal Dialysis
50%
Fructosamine
50%
Continuous Glucose Monitoring
50%
Patient with Type 2 Diabetes
50%
Hemoglobin A1c
50%
Glucose Sensor
21%
Glucose Level
14%
Glucose Blood Level
7%
Linear Regression Analysis
7%
Estimated Glomerular Filtration Rate
7%
Erythropoietin
7%
Nonoxinol 9
7%
Continuous Glucose Monitoring System
7%
Non Insulin Dependent Diabetes Mellitus
7%
Central Stimulant Agent
7%
Erythrocyte Lifespan
7%